The next board meeting for Amylyx Pharmaceuticals Inc is on 10 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Amylyx Pharmaceuticals Inc has a share price target of US$ 13, revenue growth forecast of -99.9%, and profit growth estimate of 47.5% for FY26, based on top 10 analyst calls.